These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16570357)

  • 1. Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis.
    Yamamoto-Furusho JK; Uscanga-Domínguez L; Lopez-Martinez A; Granados J
    World J Gastroenterol; 2006 Mar; 12(10):1617-20. PubMed ID: 16570357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA-DRB1 alleles and anti-neutrophil cytoplasmic antibodies in Han and Uyghur patients with ulcerative colitis in China.
    Gao F; Aheman A; Lu JJ; Abuduhadeer M; Li YX; Kuerbanjiang A
    J Dig Dis; 2014 Jun; 15(6):299-305. PubMed ID: 24597629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis.
    Yamamoto-Furusho JK; Uscanga LF; Vargas-Alarcón G; Ruiz-Morales JA; Higuera L; Cutiño T; Rodríguez-Pérez JM; Villarreal-Garza C; Granados J
    Hum Immunol; 2003 Jan; 64(1):119-23. PubMed ID: 12507822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis?
    Heresbach D; Alizadeh M; Reumaux D; Colombel JF; Delamaire M; Danze PM; Gosselin M; Genetet B; Bretagne JF; Semana G
    J Autoimmun; 1996 Dec; 9(6):777-84. PubMed ID: 9115580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.
    Hirv K; Seyfarth M; Uibo R; Kull K; Salupere R; Latza U; Rink L
    Scand J Gastroenterol; 1999 Oct; 34(10):1025-32. PubMed ID: 10563674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature.
    Annese V; Piepoli A; Latiano A; Lombardi G; Napolitano G; Caruso N; Cocchiara E; Accadia L; Perri F; Andriulli A
    Dis Colon Rectum; 2005 Jan; 48(1):57-64; discussion 64-5. PubMed ID: 15690658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis.
    Yamamoto-Furusho JK; Uscanga LF; Vargas-Alarcón G; Rodríguez-Pérez JM; Zuñiga J; Granados J
    Immunol Lett; 2004 Aug; 95(1):31-5. PubMed ID: 15325795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis.
    Folwaczny C; Zahn R; Brünnler G; Albert E; Koenig A; Noehl N; Loeschke K; Fricke H
    Z Gastroenterol; 1999 Feb; 37(2):133-40. PubMed ID: 10190246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
    Yang H; Rotter JI; Toyoda H; Landers C; Tyran D; McElree CK; Targan SR
    J Clin Invest; 1993 Aug; 92(2):1080-4. PubMed ID: 8349790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey.
    Uyar FA; Imeryüz N; Saruhan-Direskeneli G; Ceken H; Ozdoğan O; Sahin S; Tözün N
    Eur J Immunogenet; 1998 Aug; 25(4):293-6. PubMed ID: 9777329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
    Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH
    Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and immunological markers in pouchitis.
    Brett PM; Yasuda N; Yiannakou JY; Herbst F; Ellis HJ; Vaughan R; Nicholls RJ; Ciclitira PJ
    Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):951-5. PubMed ID: 8930557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study.
    Myung SJ; Yang SK; Jung HY; Chang HS; Park B; Hong WS; Kim JH; Min I
    Int J Colorectal Dis; 2002 Jul; 17(4):233-7. PubMed ID: 12073071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinuclear anti-neutrophil cytoplasmic antibodies (p-anca) in chronic ulcerative colitis: experience in a Mexican institution.
    Yamamoto-Furusho JK; Takahashi-Monroy T; Vergara-Fernandez O; Reyes E; Uscanga L
    World J Gastroenterol; 2006 Jun; 12(21):3406-9. PubMed ID: 16733859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA association and occurrence of autoantibodies in Asian-Indian patients with ulcerative colitis.
    Habeeb MA; Rajalingam R; Dhar A; Kumar A; Sharma MP; Mehra NK
    Am J Gastroenterol; 1997 May; 92(5):772-6. PubMed ID: 9149183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease.
    Mahler M; Bogdanos DP; Pavlidis P; Fritzler MJ; Csernok E; Damoiseaux J; Bentow C; Shums Z; Forbes A; Norman GL
    Clin Chim Acta; 2013 Sep; 424():267-73. PubMed ID: 23806819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping.
    Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease].
    García-Herola A; Nos P; Hoyos M; Hinojosa J; Molés JR; Pascual S; Bustamante M; Sánchez Cuenca JM; Carmona E; Ponce J; Berenguer J
    Gastroenterol Hepatol; 1998 Apr; 21(4):169-73. PubMed ID: 9633176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression.
    Futami S; Aoyama N; Honsako Y; Tamura T; Morimoto S; Nakashima T; Ohmoto A; Okano H; Miyamoto M; Inaba H
    Dig Dis Sci; 1995 Apr; 40(4):814-8. PubMed ID: 7720475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup.
    Duerr RH; Neigut DA
    Gastroenterology; 1995 Feb; 108(2):423-7. PubMed ID: 7835583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.